Nanoparticle drugs—tiny containers packed with medicine and with the potential to be shipped straight to tumors—were thought to be a possible silver bullet against cancer. However new cancer drugs based on nanoparticles ...
Jan 13, 2015
0
30
A new study identifies a gene that is especially active in aggressive subtypes of breast cancer. The research suggests that an overactive BCL11A gene drives triple-negative breast cancer development and progression.
Jan 9, 2015
0
757
Among women with triple-negative breast cancer, the benefit of adding bevacizumab to standard presurgery chemotherapy was greater for those whose cancers were classified as basal-like by gene expression assay compared with ...
Dec 12, 2014
0
0
In patients with metastatic triple-negative breast cancer—a disease with no approved targeted therapies—infusion of pembrolizumab produced durable responses in almost one out of five patients enrolled in a phase-Ib clinical ...
Dec 10, 2014
0
0
(HealthDay)—Two preliminary studies into medications under development may offer some hope for women with advanced breast cancer. The findings are scheduled for presentation Wednesday at the annual San Antonio Breast Cancer ...
Dec 10, 2014
0
0
A University of Colorado Cancer Center study being presented at the San Antonio Breast Cancer Symposium shows that triple negative breast cancer cells process tryptophan to promote survival while traveling through the body ...
Dec 10, 2014
0
3
Triple-negative breast cancer is as bad as it sounds. The cells that form these tumors lack three proteins that would make the cancer respond to powerful, customized treatments. Instead, doctors are left with treating these ...
Dec 8, 2014
0
1
Most patients with triple-negative breast cancer should undergo genetic testing for mutations in known breast cancer predisposition genes, including BRCA1 and BRCA2, a Mayo Clinic-led study has found. The findings come from ...
Dec 2, 2014
0
0
"Triple-negative" breast cancer (TNBC) occurs in patients whose cells do not express receptors for estrogen, progesterone, and/or human epidermal growth factor receptor 2 (ER-/PR-/HER2-). Because of the absence of these predictive ...
Dec 2, 2014
0
0
After having two children in her 30s, Brianna Hinojosa-Flores had been vigilant about getting mammograms and performing breast self-exams, as suggested by her gynecologist. But when she ran for a congressional seat in 2012, ...
Oct 3, 2014
0
0
